Jinming Wang

State Key Laboratory Of Systems Medicine For Cancer
Shanghai, 200127, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

The Zeb1/system Xc- axis safeguards iron-loaded cancer-associated fibroblasts against ferroptosis and promotes immunosuppression in prostate cancer.

The Zeb1/system Xc- axis safeguards iron-loaded cancer-associated fibroblasts against ferroptosis and promotes immunosuppression in prostate cancer.

Journal: Cancer letters
Published: July 16, 2025

O-GalNAc Glycosylation Activates MBL-Mediated Complement and Coagulation Cascades to Drive Organotropic Metastasis.

O-GalNAc Glycosylation Activates MBL-Mediated Complement and Coagulation Cascades to Drive Organotropic Metastasis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 17, 2025

Interleukin 15-Presenting Nanovesicles with Doxorubicin-Loaded Ferritin Cores for Cancer Immunochemotherapy.

Interleukin 15-Presenting Nanovesicles with Doxorubicin-Loaded Ferritin Cores for Cancer Immunochemotherapy.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 05, 2024

5-HT orchestrates histone serotonylation and citrullination to drive neutrophil extracellular traps and liver metastasis.

5-HT orchestrates histone serotonylation and citrullination to drive neutrophil extracellular traps and liver metastasis.

Journal: The Journal of clinical investigation
Published: June 03, 2024

A Gremlin 1-expressing splenic niche cell population restrains chronic myeloid leukemia by antagonizing the BMP pathway.

A Gremlin 1-expressing splenic niche cell population restrains chronic myeloid leukemia by antagonizing the BMP pathway.

Journal: Nature cancer
Published: April 09, 2024

Iron-loaded cancer-associated fibroblasts induce immunosuppression in prostate cancer.

Iron-loaded cancer-associated fibroblasts induce immunosuppression in prostate cancer.

Journal: Nature communications
Published: January 05, 2024

Zeb1-controlled metabolic plasticity enables remodeling of chromatin accessibility in the development of neuroendocrine prostate cancer.

Zeb1-controlled metabolic plasticity enables remodeling of chromatin accessibility in the development of neuroendocrine prostate cancer.

Journal: Cell death and differentiation
Published: October 13, 2023

ADORA2A-driven proline synthesis triggers epigenetic reprogramming in neuroendocrine prostate and lung cancers.

ADORA2A-driven proline synthesis triggers epigenetic reprogramming in neuroendocrine prostate and lung cancers.

Journal: The Journal of clinical investigation
Published: January 10, 2023

IL-1β Is an Androgen-Responsive Target in Macrophages for Immunotherapy of Prostate Cancer.

IL-1β Is an Androgen-Responsive Target in Macrophages for Immunotherapy of Prostate Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 23, 2022

EHD2 inhibits the invasive ability of lung adenocarcinoma and improves the prognosis of patients.

EHD2 inhibits the invasive ability of lung adenocarcinoma and improves the prognosis of patients.

Journal: Journal of thoracic disease
Published: May 30, 2022

Numb/Parkin-directed mitochondrial fitness governs cancer cell fate via metabolic regulation of histone lactylation.

Numb/Parkin-directed mitochondrial fitness governs cancer cell fate via metabolic regulation of histone lactylation.

Journal: Cell reports
Published: May 03, 2022

Development and validation of a prognostic model for stage I-IIA non-small cell lung cancer: A study based on the SEER database.

Development and validation of a prognostic model for stage I-IIA non-small cell lung cancer: A study based on the SEER database.

Journal: Asian journal of surgery
Published: April 07, 2022
Showing 1-12 of 24

Last Updated: 09/26/2026